Phenylephrine Hydrochloride In 0.9% Sodium Chloride is a drug owned by Dr Reddys Laboratories Sa. It is protected by 1 US drug patent filed in 2026 out of which none have expired yet. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 08, 2044. Details of Phenylephrine Hydrochloride In 0.9% Sodium Chloride's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US12564561 | NA |
Aug, 2044
(18 years from now) | Active |
US patents provide insights into the exclusivity only within the United States, but
Phenylephrine Hydrochloride In 0.9% Sodium Chloride is protected by patents in multiple countries.
Understanding
the full scope
of patent protection is crucial in strategizing market entry. By looking at the broader patent
landscape, you can
identify markets with weaker patent protection which could be ideal generic entry points. The
following section offers
details on Phenylephrine Hydrochloride In 0.9% Sodium Chloride's family patents as well as insights into
ongoing legal events
on those patents.
Phenylephrine Hydrochloride In 0.9% Sodium Chloride's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Phenylephrine Hydrochloride In 0.9% Sodium Chloride's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 08, 2044 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Phenylephrine Hydrochloride In 0.9% Sodium Chloride Generic API suppliers:
Phenylephrine Hydrochloride is the generic name for the brand Phenylephrine Hydrochloride In 0.9% Sodium Chloride. 18 different companies have already filed for the generic of Phenylephrine Hydrochloride In 0.9% Sodium Chloride, with Caplin having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Phenylephrine Hydrochloride In 0.9% Sodium Chloride's generic
Alternative Brands for Phenylephrine Hydrochloride In 0.9% Sodium Chloride
There are several other brand drugs using the same active ingredient (Phenylephrine Hydrochloride) as Phenylephrine Hydrochloride In 0.9% Sodium Chloride. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Eyenovia |
| |
| Hikma |
| |
| Paragon Bioteck |
| |
| Rayner Surgical |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Phenylephrine Hydrochloride, Phenylephrine Hydrochloride In 0.9% Sodium Chloride's active ingredient. Check the complete list of approved generic manufacturers for Phenylephrine Hydrochloride In 0.9% Sodium Chloride
About Phenylephrine Hydrochloride In 0.9% Sodium Chloride
Phenylephrine Hydrochloride In 0.9% Sodium Chloride is a drug owned by Dr Reddys Laboratories Sa. Phenylephrine Hydrochloride In 0.9% Sodium Chloride uses Phenylephrine Hydrochloride as an active ingredient. Phenylephrine Hydrochloride In 0.9% Sodium Chloride was launched by Dr Reddys in 2025.
Approval Date:
Phenylephrine Hydrochloride In 0.9% Sodium Chloride was approved by FDA for market use on 30 May, 2025.
Active Ingredient:
Phenylephrine Hydrochloride In 0.9% Sodium Chloride uses Phenylephrine Hydrochloride as the active ingredient. Check out other Drugs and Companies using Phenylephrine Hydrochloride ingredient
Dosage:
Phenylephrine Hydrochloride In 0.9% Sodium Chloride is available in solution form for intravenous use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 20MG/250ML (0.08MG/ML) | SOLUTION | Prescription | INTRAVENOUS |